NCT07363122 is a clinical trial in Platelet Indices, sponsored by Assiut University.

Who is sponsoring NCT07363122?

NCT07363122 is sponsored by Assiut University.

What condition does NCT07363122 study?

NCT07363122 studies Platelet Indices, Type 2 Diabetes, Inflammatory Markers.

Is NCT07363122 still recruiting?

NCT07363122 is currently not yet recruiting. Last updated 15 January 2026.

Last reviewed 2026-01-15 · How we verify

NCT07363122

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Platelet Indices Changes in Type 2 Diabetes Mellitus and Their Relationship With Inflammatory Markers

Not yet recruiting Last updated 15 January 2026

What this trial tests

trial in Platelet Indices in 200 participants. Not yet recruiting.

Timeline

1 February 2026

Primary endpoint
1 February 2027

1 March 2027

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 February 2026
Primary completion	1 February 2027
Estimated completion	1 March 2027

Conditions studied

Platelet Indices — all drugs for Platelet Indices →
Type 2 Diabetes — all drugs for Type 2 Diabetes →
Inflammatory Markers — all drugs for Inflammatory Markers →

Sponsor

Assiut University

Who can join

Adults 30 to 70, any sex, with Platelet Indices or Type 2 Diabetes. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Mean Platelet Volume (MPV)
Time frame: Single measurement at enrollment
Difference in mean platelet volume (MPV) measured from complete blood count between T2DM patients and healthy controls. MPV reflects platelet activation and size, expected to be elevated in T2DM due to inflammation and hyperglycemia.

Sponsor's own description

This study examines changes in platelet indices in people with type 2 diabetes compared to healthy people. It checks if these changes relate to inflammation markers (like hs-CRP) and blood sugar control. Participants get routine blood tests during one clinic visit at Assiut University Hospitals. No treatments or extra procedures are involved.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07363122 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 15 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07363122.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing